Clinical Trial 7149

Mesa, AZ 85206

Study Summary:

Novara Clinical Research is looking for pediatric subjects to participate in a clinical research study of an investigational drug, MK-0462 (rizatriptan) compared to placebo (an inactive substance) in pediatric subjects ages 6-17 with migraines.

This study lasts approximately 4 months and has 2 office visits. One of our staff will be happy to give you further information regarding this study and will schedule you an appointment so you may review the study in more detail with one of our study physicians. If you know of anyone that might be interested in this study, please feel free to pass this information along to them.

Qualified Participants Must:

• Your child has had at least one, but not more than 8 moderate or severe migraine attacks per month for the past 2 months
• Your child cannot have experienced satisfactory relief of their migraine pain through acetaminophen or any NSAIDs (e.g. ibuprofen, aleve)
• Parent or guardian must accompany child to first appointment

Qualified Participants May Receive:

Study-related drugs (may include placebo), lab work, and study-related physical exams are provided to participants in this study at no cost. Compensation is available to qualified participants for each completed visit for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.